- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
KRAS-Associated Cancer Signaling
This special issue belongs to the section “Molecular Oncology“.
Special Issue Information
Dear Colleagues,
Oncogenic KRAS orchestrates cancer signalling across colorectal, lung, and pancreatic malignancies through dynamic crosstalk with receptor tyrosine kinases, downstream MAPK/PI3K pathways, and the tumour microenvironment. Despite recent advances, including covalent KRASG12C inhibitors, adaptive rewiring, lineage context, and KRAS-independent survival circuits continue to limit durable responses. This Special Issue will gather mechanistic and translational studies that dissect KRAS-associated networks and therapeutic vulnerabilities, including RTK and membrane-proximal organizers (e.g., EGFR, c-MET, laminin receptor, prion protein), biomarker-driven patient stratification, and rational combinations with chemotherapy, targeted agents, or immunotherapy. We welcome original research, brief reports, and reviews using cellular and animal models, organoids, multi-omics, and computational approaches that inform clinically actionable strategies and early clinical translation.
Dr. Sang Hun Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- KRAS signaling
- receptor tyrosine kinases
- EGFR
- c-MET
- PI3K–MAPK pathways
- tumor microenvironment
- drug resistance and adaptive rewiring
- combination therapy
- biomarker stratification
- prion protein (PrPC)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

